Bombardieri E - Search Results

1

Alpha-fetoprotein (AFP) in germ cell tumors of the testis.

Seregni E, Savelli G, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. J Nucl Med Allied Sci. 1989 Jul-Sep;33(3 Suppl):42-5. J Nucl Med Allied Sci. 1989. PMID: 2480421 Review. No abstract available.

2

Mucinic tumor markers recognized by monoclonal antibodies.

Seregni E, Bombardieri E, Maffioli L, Buraggi GL. Seregni E, et al. Among authors: bombardieri e. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):314-20. J Nucl Med Allied Sci. 1990. PMID: 2090797 Review. No abstract available.

3

Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms.

Seregni E, Botti C, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Anticancer Res. 1995 Jul-Aug;15(4):1491-9. Anticancer Res. 1995. PMID: 7544570 Review.

4

Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.

Seregni E, Massimino M, Nerini Molteni S, Pallotti F, van der Hiel B, Cefalo G, Spreafico F, Fossati F, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Int J Biol Markers. 2002 Apr-Jun;17(2):112-8. doi: 10.1177/172460080201700206. Int J Biol Markers. 2002. PMID: 12113577 Free article.

5

Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results.

Seregni E, Chiti A, Bombardieri E. Seregni E, et al. Among authors: bombardieri e. Eur J Nucl Med. 1998 Jun;25(6):639-58. doi: 10.1007/s002590050267. Eur J Nucl Med. 1998. PMID: 9618580 Review.

6

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours.

Savelli G, Lucignani G, Seregni E, Marchianò A, Serafini G, Aliberti G, Villano C, Maccauro M, Bombardieri E. Savelli G, et al. Among authors: bombardieri e. Nucl Med Commun. 2004 May;25(5):445-9. doi: 10.1097/00006231-200405000-00004. Nucl Med Commun. 2004. PMID: 15100502 Clinical Trial.

7

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

Bombardieri E, Martinetti A, Miceli R, Mariani L, Castellani MR, Seregni E. Bombardieri E, et al. Eur J Nucl Med. 1997 Nov;24(11):1349-55. doi: 10.1007/s002590050159. Eur J Nucl Med. 1997. PMID: 9371866 Clinical Trial.

8

111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.

Bombardieri E, Chiti A, Crippa F, Seregni E, Cataldo I, Maffioli L, Soresi E. Bombardieri E, et al. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):104-7. Q J Nucl Med. 1995. PMID: 9002763

9

Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours.

Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, van Graafeiland BJ, Monetti N, Bombardieri E. Chiti A, et al. Among authors: bombardieri e. Eur J Nucl Med. 1998 Oct;25(10):1396-403. doi: 10.1007/s002590050314. Eur J Nucl Med. 1998. PMID: 9818279 Clinical Trial.

10

Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.

Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, Decise D, De Sanctis V, Greco M, Daidone MG, Bombardieri E. Crippa F, et al. Among authors: bombardieri e. Eur J Nucl Med. 1998 Oct;25(10):1429-34. doi: 10.1007/s002590050319. Eur J Nucl Med. 1998. PMID: 9818284 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters